Search Within

Aaron David Goldberg

  1. "Department of Pathology and Laboratory Medicine"
Formats
  1. Meeting Abstract (12)
  2. Journal Article (11)
  3. Research Letter (1)
Groups
  1. Adult Leukemia (24)
  2. Center for Hematologic Malignancies (24)
  3. Department of Medicine (24)
  4. Department of Pathology and Laboratory Medicine (24)
  5. Hematologic Malignancies, Division of (24)
  6. Weinberg Fellows (24)

More Groups

People
  1. Christopher Famulare (21)
  2. Martin Tallman (18)
  3. Ross Levine (18)
  4. Mikhail Roshal (17)
  5. Eytan Stein (14)
  6. Jacob Glass (14)

More People

Years
  1. 2025 (1)
  2. 2023 (5)
  3. 2022 (2)
  4. 2021 (4)
  5. 2020 (5)
  6. 2019 (3)

More Years

Publications
  1. Blood (12)
  2. Blood Advances (3)
  3. American Journal of Hematology (2)
  4. Leukemia and Lymphoma (2)
  5. Cancer Discovery (1)
  6. Haematologica (1)

More Publications

Publishers
  1. American Society of Hematology (15)
  2. American Society of Clinical Oncology (2)
  3. John Wiley & Sons, Inc. (2)
  4. Taylor & Francis Group (2)
  5. Amer Assoc Advancement Science (1)
  6. American Association for Cancer Research (1)

More Publishers

Results (24)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Loss of plasmacytoid dendritic cell differentiation is highly predictive for persistent measurable residual disease and poor outcomes in acute myeloid leukemia
    Meeting Abstract

    Xiao, W.; Goldberg, A. D.; Famulare, C.; Delvin, S.; Patel, M.; McGovern, E.; Patel, A.; Schulman, J.; Dunbar, A.; Epstein-Peterson, Z. D.; more...
    Blood (2018)

    Fulltext@MSK | Save
  • PHF6 mutations are mutually exclusive to TP53 mutations, and define a distinct subgroup of secondary acute myeloid leukemia associated with a primitive stem/progenitor immunophenotype, absent complex karyotype and relatively better outcomes
    Meeting Abstract

    Xiao, W.; Goldberg, A. D.; Ball, B.; Famulare, C.; Pastore, F.; Tallman, M. S.; Zhang, Y.; Arcila, M. E.; Papaemmanuil, E.; Levine, R. L.; more...
    Blood (2018)

    Fulltext@MSK | Save
  • Molecular predictors and current management of minimal residual disease (MRD) following induction chemotherapy for acute myeloid leukemia (AML)
    Meeting Abstract

    Goldberg, A. D.; Famulare, C.; Devlin, S. M.; Farnoud, N.; Menghrajani, K.; Patel, M.; Cai, S.; Dunbar, A.; Epstein-Peterson, Z. D.; McGovern, E.; more...
    Blood (2018)

    Fulltext@MSK | Save
  • Molecular profiling in extramedullary acute myeloid leukemia reveals distinct subgroups defined by mutations in KIT and RUNX1
    Meeting Abstract

    Goldberg, A. D.; Farnoud, N.; Goldberger, C.; Patel, M.; Famulare, C.; Medina, J.; Rampal, R. K.; Levine, R. L.; Berman, E.; Zhang, Y.; more...
    Blood (2017)

    Fulltext@MSK | Save